Caplin Point Laboratories has commenced commercial Production at its state of art injectable Plant near Gummidipoondi, Tamil Nadu on March 27, 2014 to cater regulated markets USA, EU, Brazil, South Africa etc. This will now enable export of these products to Semi regulated and non regulated markets.
The Company has initiated the process of submitting required documents for obtaining approval from regulatory bodies such as UKMHRA, ANVISA, BRAZIL, USFDA, EUGMP which would enable export of Injectables in various dosage forms to the regulated markets besides offering contract manufacturing for export to these markets.
Caplin Point Laboratories is engaged in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
